Bepirovirsen Market: Size, Forecast and Outlook After FDA Approval
Bepirovirsen market to reach USD 2.12 billion by 2035 at 29.6% CAGR after Hibsago FDA approval. Segments, regional outlook, competitors and adoption hurdles.
Once-Monthly Olanzapine Injection: 1st FDA Approval Revealed
The once-monthly olanzapine injection Weltruza gets FDA approval for adults with schizophrenia. Doses, SOLARIS data, safety and launch timing.